Evolving role of FDG PET imaging in assessing joint disorders: a systematic review

Assessing joint disorders has been a relatively recent and evolving application of 18F-2-fluoro-2-deoxy-D-glucose (FDG) positron emission tomography (PET) imaging. FDG is taken up by inflammatory cells, particularly when they are active as part of an ongoing inflammatory process. Hence FDG PET has been employed to assess a wide array of arthritic disorders. FDG PET imaging has been investigated in various joint diseases for diagnostic purposes, treatment monitoring, and as a prognostic indicator as in other disorders. In some of the diseases the ancillary findings in FDG PET have provided important clues about the underlying pathophysiology and pathogenesis processes. While substantial promise has been demonstrated in a number of studies, it is clear that the potential utility of PET in this clinical realm far outweighs that which has been established to date.

[1]  V. Treyer,et al.  F-18 FDG Whole-Body PET for the Assessment of Disease Activity in Patients With Rheumatoid Arthritis , 2006, Clinical nuclear medicine.

[2]  R. Moskowitz,et al.  Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. , 1986, Arthritis and rheumatism.

[3]  P. Surányi,et al.  99mTc-HMPAO labelled leukocyte scintigraphy in patients with rheumatoid arthritis: a comparison with disease activity , 2002, Nuclear medicine communications.

[4]  M Ostergaard,et al.  Quantification of synovistis by MRI: correlation between dynamic and static gadolinium-enhanced magnetic resonance imaging and microscopic and macroscopic signs of synovial inflammation. , 1998, Magnetic resonance imaging.

[5]  G. V. von Schulthess,et al.  Joint accumulations of FDG in whole body PET scans , 2001, Nuklearmedizin.

[6]  A. Alavi,et al.  Rapid normalization of osseous FDG uptake following traumatic or surgical fractures , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[7]  Habib Zaidi,et al.  Novel quantitative techniques for assessing regional and global function and structure based on modern imaging modalities: implications for normal variation, aging and diseased states. , 2007, Seminars in nuclear medicine.

[8]  K. Kubota,et al.  Whole-body FDG-PET/CT on rheumatoid arthritis of large joints , 2009, Annals of nuclear medicine.

[9]  M. Hsieh,et al.  Using 18F-FDG microPET imaging to measure the inhibitory effects of Clematis chinensis Osbeck on the pro-inflammatory and degradative mediators associated with inflammatory arthritis. , 2011, Journal of ethnopharmacology.

[10]  A. Maes,et al.  Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch. , 2000, The American journal of medicine.

[11]  K. Yudoh,et al.  Positron emission tomography with 18F-FDG in osteoarthritic knee. , 2007, Osteoarthritis and cartilage.

[12]  N. Olsen,et al.  Assessment of disease activity in rheumatoid arthritis. , 1989, Current opinion in rheumatology.

[13]  F. Lecouvet,et al.  CT arthrography, MR arthrography, PET, and scintigraphy in osteoarthritis. , 2009, Radiologic clinics of North America.

[14]  A. Alavi,et al.  Functional imaging of inflammatory diseases using nuclear medicine techniques. , 2009, Seminars in nuclear medicine.

[15]  A. Wunder,et al.  Molecular imaging: novel tools in visualizing rheumatoid arthritis. , 2005, Rheumatology.

[16]  K. Ohtomo,et al.  Inflammatory Cytokines and Hypoxia Contribute to 18F-FDG Uptake by Cells Involved in Pannus Formation in Rheumatoid Arthritis , 2009, Journal of Nuclear Medicine.

[17]  W E Palmer,et al.  Quantification of inflammation in the wrist with gadolinium-enhanced MR imaging and PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. , 1995, Radiology.

[18]  A. Alavi,et al.  Facet joint arthropathy demonstrated on FDG-PET. , 2006, Clinical nuclear medicine.

[19]  B. Dijkmans,et al.  Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial. , 2005, Arthritis and rheumatism.

[20]  H. Fukuda,et al.  Atlantoaxial osteoarthritis in rheumatoid arthritis: FDG PET/CT findings. , 2006, Clinical nuclear medicine.

[21]  A. Lammertsma,et al.  2-Deoxy-2-[F-18]fluoro-D-glucose Joint Uptake on Positron Emission Tomography Images: Rheumatoid Arthritis Versus Osteoarthritis , 2007, Molecular Imaging and Biology.

[22]  W. Oyen,et al.  Radiolabelled interleukin-1 receptor antagonist for detection of synovitis in patients with rheumatoid arthritis. , 2000, Rheumatology.

[23]  R. Boellaard,et al.  Quantification of (R)-[11C]PK11195 binding in rheumatoid arthritis , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[24]  Ren-Shyan Liu,et al.  F-18 FDG PET/CT of polymyalgia rheumatica. , 2009, Clinical nuclear medicine.

[25]  R. Pichler,et al.  Bone scintigraphy using Tc‐99m DPD and F18‐FDG in a patient with SAPHO syndrome , 2003, Scandinavian journal of rheumatology.

[26]  J. Powe,et al.  Fluorine-18-fluorodeoxyglucose uptake in rheumatoid arthritis-associated lung disease in a patient with thyroid cancer. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[27]  E. Lin,et al.  FDG uptake in cervical facet subchondral cysts demonstrated by PET/CT. , 2008, Clinical nuclear medicine.

[28]  A. Fischman,et al.  Use of magnetic resonance imaging and positron emission tomography in the assessment of synovial volume and glucose metabolism in patients with rheumatoid arthritis. , 1995, Arthritis and rheumatism.

[29]  L. A. Healey,et al.  Remodeling the pyramid--a concept whose time has come. , 1989, The Journal of rheumatology.

[30]  A. Alavi,et al.  Nonprosthesis orthopedic applications of (18)F fluoro-2-deoxy-D-glucose PET in the detection of osteomyelitis. , 2007, Radiologic clinics of North America.

[31]  M. Roarke,et al.  F-18 FDG PET/CT incidental finding of large ischiogluteal bursitis. , 2007, Clinical nuclear medicine.

[32]  H. Paulus,et al.  Analysis of improvement in individual rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs, based on the findings in patients treated with placebo. The Cooperative Systematic Studies of Rheumatic Diseases Group. , 1990, Arthritis and rheumatism.

[33]  Riitta Parkkola,et al.  Use of positron emission tomography with methyl-11C-choline and 2-18F-fluoro-2-deoxy-D-glucose in comparison with magnetic resonance imaging for the assessment of inflammatory proliferation of synovium. , 2003, Arthritis and rheumatism.

[34]  V. Strand,et al.  Rheumatoid arthritis classification criteria - It's finally time to move on! , 2010, Bulletin of the NYU hospital for joint diseases.

[35]  A. Silman,et al.  UvA-DARE (Digital Academic Repository) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative Aletaha, , 2010 .

[36]  Y. Kirino,et al.  Multiple extra-articular synovial cysts complicated with rheumatoid arthritis , 2009, Modern rheumatology.

[37]  A. Alavi,et al.  PET/MRI depicts the exact location of meniscal tear associated with synovitis , 2006, European Journal of Nuclear Medicine and Molecular Imaging.

[38]  J. Babb,et al.  Diffuse FDG shoulder uptake on PET is associated with clinical findings of osteoarthritis. , 2005, AJR. American journal of roentgenology.

[39]  P. Quartier,et al.  Juvenile Idiopathic Arthritis: Classification, Clinical Presentation and Current Treatments , 2009, Hormone Research in Paediatrics.

[40]  A. Alavi,et al.  Persistent non-specific FDG uptake on PET imaging following hip arthroplasty , 2002, European Journal of Nuclear Medicine and Molecular Imaging.

[41]  A. Alavi,et al.  Magnetic Resonance Imaging Based Bone Marrow Segmentation for Quantitative Calculation of Pure Red Marrow Metabolism Using 2-Deoxy-2-[F-18]fluoro-d-glucose- Positron Emission Tomography: a Novel Application with Significant Implications for Combined Structure–Function Approach , 2007, Molecular Imaging and Biology.

[42]  G. V. von Schulthess,et al.  FDG positron emission tomography for differentiation of degenerative and infectious endplate abnormalities in the lumbar spine detected on MR imaging. , 2002, AJR. American journal of roentgenology.

[43]  F. Breedveld,et al.  Arthritis of the large joints—in particular, the knee—at first presentation is predictive for a high level of radiological destruction of the small joints in rheumatoid arthritis , 2006, Annals of the rheumatic diseases.

[44]  J. Mountz,et al.  Specific targeting of activated endothelium in rat adjuvant arthritis with a 99mTc-radiolabeled E-selectin-binding peptide. , 1999, Arthritis and rheumatism.

[45]  H. Muir,et al.  In vivo and in vitro stimulation of chondrocyte biosynthetic activity in early experimental osteoarthritis. , 1984, Arthritis and rheumatism.

[46]  W. Brenner.  18F-FDG PET in rheumatoid arthritis: there still is a long way to go. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[47]  R. Loeser.  Molecular mechanisms of cartilage destruction: mechanics, inflammatory mediators, and aging collide. , 2006, Arthritis and rheumatism.

[48]  S. Abramson,et al.  Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. , 2001, Arthritis and rheumatism.

[49]  S Totterman,et al.  MRI and non-cartilaginous structures in knee osteoarthritis. , 2006, Osteoarthritis and cartilage.

[50]  U. Haberkorn,et al.  [18F]FLT; portrait of a proliferation marker. , 2002, European journal of nuclear medicine and molecular imaging.

[51]  A. Rai,et al.  Spinal cord compression by tophaceous gout with fluorodeoxyglucose-positron-emission tomographic/MR fusion imaging. , 2006, AJNR. American journal of neuroradiology.

[52]  A. Silman,et al.  Rheumatoid arthritis classifi cation criteria : an American College of Rheumatology / European League Against Rheumatism collaborative initiative , 2010 .

[53]  M. Ostergaard,et al.  Established rheumatoid arthritis - new imaging modalities. , 2007, Best practice & research. Clinical rheumatology.

[54]  M. Zanetti,et al.  Therapeutic impact of [18F]fluoride positron-emission tomography/computed tomography on patients with unclear foot pain , 2010, Skeletal Radiology.

[55]  J. Cardot,et al.  FDG-PET/CT scan of inflammatory spondylodiscitis lesions in ankylosing spondylitis, and short term evolution during anti-tumour necrosis factor treatment , 2005, Annals of the rheumatic diseases.

[56]  A. Alavi,et al.  F-18 FDG Uptake in a Patient with Psoriatic Arthritis: Imaging Correlation with Patient Symptoms , 2001, Clinical nuclear medicine.

[57]  J. Block,et al.  Pseudo-septic hip arthritis as the presenting symptom of ankylosing spondylitis: a case series and review of the literature. , 2010, Clinical and experimental rheumatology.

[58]  K. Takagishi,et al.  Gouty tophus of the patella evaluated by PET imaging , 2001, Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association.

[59]  Roland Hustinx,et al.  18F-FDG PET imaging of rheumatoid knee synovitis correlates with dynamic magnetic resonance and sonographic assessments as well as with the serum level of metalloproteinase-3 , 2006, European Journal of Nuclear Medicine and Molecular Imaging.

[60]  L. Mortelmans,et al.  Repetitive 18-fluorodeoxyglucose positron emission tomography in isolated polymyalgia rheumatica: a prospective study in 35 patients. , 2005, Rheumatology.

[61]  R. Hustinx,et al.  Assessment of disease activity in rheumatoid arthritis with (18)F-FDG PET. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[62]  A. Alavi,et al.  Potential role of FDG PET in the setting of diabetic neuro-osteoarthropathy: can it differentiate uncomplicated Charcot's neuroarthropathy from osteomyelitis and soft-tissue infection? , 2007, Nuclear medicine communications.

[63]  L. Fayad,et al.  Increased 18F-FDG uptake in degenerative disease of the spine: Characterization with 18F-FDG PET/CT. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[64]  Abass Alavi,et al.  Functional Imaging of Cancer with Emphasis on Molecular Techniques , 2007, CA: a cancer journal for clinicians.

[65]  PET assessment of disease activity in children with juvenile idiopathic arthritis , 2010, Pediatric Radiology.

[66]  W. Oyen,et al.  FDG-PET/CT can visualise the extent of inflammation in rheumatoid arthritis of the tarsus , 2007, European Journal of Nuclear Medicine and Molecular Imaging.